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Abstract 
The aim of an exploratory clinical trial is to determine whether a new 
intervention is promising for further testing in confirmatory clinical trials. 
Most exploratory clinical trials are designed as single-arm trials using a 
binary outcome with or without interim monitoring for early stopping. In this 
paper, we are particularly interested in using the predictive Bayesian 
approach in clinical trials or objectives is the development of important 
evidence of an effect of interest we offer the procedure based on the notion 
satisfaction Index is based on the value of p and we are first given the data 
available to calculate a forecast of future satisfaction data as Bayesian 
predictive expect this index conditional on past observations. To illustrate 
the proposed procedure, we proposed the binomial model.  
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Introduction: 
The aim of exploratory clinical trials, such as phase II trials and 
proof-of-concept studies, is to determine whether a new intervention is 
promising for further testing in confirmatory clinical trials, such as phase III 
randomised controlled trials. Most exploratory clinical trials are designed as 
single-arm trials with or without interim monitoring for early stopping. In 
this setting, the efficacy of treatment is commonly evaluated using a binary 
outcome such as tumour shrinkage or response to treatment (Satoshi 
Teramukai,a, Takashi Daimonb and Sarah Zoharc, 2012). Bayesian 
approaches are ideal for such exploratory clinical trials as they take into 
account previous information about the quantity of interest as well as 
accumulated data during a trial. The clinical trial, a prospective study to 
evaluate the effect of interventions in humans under prespecified conditions, 
is a standard and integral part of modern medicine. Many adaptive and 
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sequential approaches have been proposed for use in clinical trials to allow 
adaptations or modifications to aspects of a trial after its initiation without 
undermining the validity and integrity of the trial. The application of 
adaptive and sequential methods in clinical trials has significantly improved 
the flexibility, efficiency, therapeutic effect, and validity of trials (Ton J 
Cleophas, Aeilko H Zwinderman and Toine F Cleophas, 2009). 
Prediction models are important in various fields, including medicine, 
physics, meteorology, and finance. Prediction models will become more 
relevant in the medical field with the increase in knowledge on potential 
predictors of outcome, e.g. from genetics. Also, the number of applications 
will increase, e.g. with targeted early detection of disease, and individualized 
approaches to diagnostic testing and treatment. The current era of evidence-
based medicine asks for an individualized approach to medical decision-
making. Evidence-based medicine has a central place for meta-analysis to 
summarize results from randomized controlled trials; similarly prediction 
models may summarize the effects of predictors to provide individualized 
predictions of a diagnostic or prognostic outcome, (Steyerberg, E.W, 2009) 
 In this paper we consider the prediction within the experimental 
design for this, we define a hypothesis is defined indices of satisfaction and 
anticipation of satisfaction related to a test as a decreasing function of the p-
value, satisfaction is higher than the null hypothesis is rejected wider, that is 
to say, the p-value is small. We consider the case of a two-step procedure, 
which is often done in the case of clinical trials where these satisfaction 
indices are interesting protocols and when the inference concerns an effect 
evaluated from the future sample. We treated our applications given by 
software: Matlab and R. 
The outline of the paper is as follows.. Section 2 introduces the basic 
idea of prediction in experimental design. In section 3, we propose a study 
predictive sue the binomial model, we present an illustrative example and 
conclude with a discussion in Section 4. 
 
Prediction in the experimental design: 
- Choice of model 
Specify the experimental context that consists of two successive 
experiments, results ω'ϵΩ' and ω , which are usually conducted 
independently. Laws depend in a well established model, parameter θ ϵ; only 
ω , in the case of the experimental design used to build the official 
conclusion of the study and determine the user satisfaction it will be 
appreciated  . But it is worth, based on the result of ω' the first phase, 
to predict what will be the satisfaction at the end of the second phase. In our 
study, (Christian P, Robert and George Casella, 2007), this prediction is 
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performed in a Bayesian framework, that is to say, based on the choice of a 
priori probability of .It notes:  
 : Probability of   
     : A priori probability of  
: A posteriori probability of θ, based on the result of the first phase. 
  : Law sampling of the 2nd phase 
  : Probability of Ω'' conditioned by the result of the first phase of ω' 
(not to be confused, of course , with that, because at θ fixed, the two 
experiments are independent, is none other than ). 
Recall that, according to the usual Bayesian terminology (Christian P, 
Robert and George Casella, 2004), we call predictive probability on the 
probability  space complete results. 
This will help us later on Ω' is the probability "that follows by 
conditioning by ω'. 
We propose to associate with any satisfaction index on the second 
phase of an index forecasting is the expectation with respect . In other 
words, what will be of interest to potential users of the indicator of 
satisfaction , that is, after the first phase, the prediction of the average 
value knowing ω'. Recall that the predictive probability is a valuable tool for 
planning and conducting an experiment for reasons of ethical concerns or 
because the treatment is particularly toxic and expensive,  
(BERRY S. M, CARLIN B.P., LEE J.J and MULLER P, 2011). 
 
- Index and prediction of satisfaction: 
We define the indices of satisfaction and anticipation of satisfaction 
related to a decreasing hypothesis test as a function of the p-value, 
satisfaction is higher than the null hypothesis is rejected more broadly, that is 
to say that p-value is small. We consider the case of a two-step procedure, 
which is often done in the case of clinical trials where these satisfaction 
indices are interesting protocols and when the inference concerns an effect 
evaluated from the future  
sample only. 
Consider the satisfaction provided by the second phase of the 
experiment and the predicted using the first. We saplings under which the 
statistician "wants" to observe a significant result, i.e. reject the null 
hypothesis . His "satisfaction" will be greater in the case of rejection, and 
even generally much larger than the observation that led to the rejection is 
more significant. 
European Scientific Journal   December 2013  edition vol.9, No.36  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
  
351 
 
 Being fixed α, a level α test defined by the critical first satisfaction 
index region  the study in (Merabet, H, 2004): 
                                      
The default index above that expresses satisfaction "all or nothing". It 
is interesting to consider to what extent the result will always appear 
significant. Therefore a new level of satisfaction defined is used: 
 
                                    
                                   =1-p 
 Recall that inf  is what practitioners note the 
associated  ω" and is called the p-value, it is considered a measure of 
credibility to be attached to the null hypothesis and practitioners often use to 
meet several critical and disadvantages of the approach Neymann -Pearson, 
you can see why. (Gary Koop, Dale J. Poirier, and Justin L , 2007) 
Therefore, the more that p is, the more the practitioner Considers that the 
result is significant. 
An indicator of prediction is given by: 
                      (1) 
                                   (2) 
Note that generalizes the power of the test in 
the logic of satisfaction index proposed and is different from insurance 
introduced in (O'.HAGAN A, STEVENS J.W, CAMPBELL M.J, 2005) and 
it is the practitioner to decide below which value Satisfaction Index, he gave 
up the pursuit of experience. 
 
Application 
We propose to calculate the prediction of satisfaction in several 
models where the law of the unknown parameter θ is a conjugate prior or 
uninformative and we predictive approach. The sequential aspect of 
treatment that will be adopted is a particularly innovative element relative to 
existing technology; it helps to alleviate the most ambitious multi-phase 
studies that the existing, more licensed statistical analysis, a patient both, is 
ethical because it allows a stop  shorter and less late experience. 
 We denote θ the probability that an individual suffering from a 
disease is cured with M from a treatment t (consisting of the administration 
of a drug). 
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To estimate the unknown parameter θ, T is administered to patients 
the treatment t. there , i the patient following administration of 
treatment t; = 1 if the patient i is cured and = 0 otherwise. It is also 
considered that the medication (treatment related t) may be marketed only if 
. From a statistical point of view (Shein Chung, 2007), we can 
formulate the problem using the following test: 
 
We work in the framework of the sampling model where we assume 
that are realizations of independent random variables and even Bernoulli 
parameter θ, again for the sake of completeness we take .  . If 
we choose as prior distribution for θ a beta law   is then known that 
the posterior distribution of  is still a beta law  with  
and . 
The satisfaction index for observation  ω" = 0 or 1  is: 
                                                
        (3) 
            =                                 (4) 
With 
                                     (5) 
On the other hand, the predictive density ω"=ω' is none other than 
the beta-binomial 
                                         (6) 
=      (7)         
=                                             (8) 
 
Predicting satisfaction is given by: 
 
Note that we can generalize a plan experience where  
and the Binomial model is found. 
The satisfaction index is: 
                             (9) 
                  =                    (10) 
or 
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The predictive density is: 
    (11) 
=               (12) 
=                                                        (13) 
We deduce index prediction is different from the predictive power 
given by: 
(14)
 
For example: Suppose two imaging modalities (e.g., CT vs.MRI) for 
diagnosing lung cancer are to be compared on the basis of test accuracy 
(sensitivity, specificity, and the area under the ROC curve). 
 Suppose =  =20 are the sample sizes of the two groups and the 
prior probability of the null hypotheses is p=0.5. The predictive probability 
at each point  is calculated via simulation, similar to that given by 
Equation (14) with: 
1. a = b = 0.5 
scenario ω' 
 
1 0 0.00000006 
2 1 0.000005 
3 2 0.000015 
4 3 0.000076 
5 4 0.00031 
6 5 0.00108 
7 6 0.00314 
8 7 0.00797 
9 8 0.01807 
10 9 0.0371 
11 10 0.0701 
12 11 0.1221 
13 12 0.1977 
14 13 0.2987 
15 14 0.4220 
16 15 0.5591 
17 16 0.6957 
18 17 0.8153 
19 18 0.9040 
20 19 0.9559 
21 20 0.9765 
TableI: prediction with a = b = 0.5 
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Figure. I: the graphical presentation of prediction 
 
We note in Table I, where ω' is included in [0, 17], the result of p = 
0.5 varies from 0.00000006 to 0.8153. Therefore we conclude for Y <17. 
On the other hand, when ω' is included in [18, 20] the result p varies from 
0.9040 to 0.9765. In this case, instead of deciding for  considering the 
predictive probability is the weighted average of the indicator of a test  
which runs until the end of the study. 
2. a=b=1 
Scenario ω' 
 
1 0 0.0000007 
2 1 0.000006 
3 2 0.00002 
4 3 0.00010 
5 4 0.00039 
6 5 0.00125 
7 6 0.0034 
8 7 0.0083 
9 8 0.0183 
10 9 0.0367 
11 10 0.0679 
12 11 0.1166 
13 12 0.1869 
14 13 0.2809 
15 14 0.3965 
16 15 0.5269 
17 16 0.6602 
18 17 0.7818 
19 18 0.8779 
20 19 0.9404 
21 20 0.9708 
Table. II: Representation of prediction with a = b = 1 
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Figure. II: Graphical representation of prediction with a = b = 1 
 
We note in Table II where ω is included in [0, 18], the result of p = 
0.5varies from 0.0000007 to 0.8153. Therefore we conclude  for Y <18. 
On the other hand, when ω is included in [18, 20] the result p varies from 
0.9040 to 0.9765. In this case, instead of deciding for  considering the 
predictive probability is the weighted average of the indicator of a test which  
runs until the end of the study. 
As can be concluded from two tables when the parameters of the beta 
law are equal and equal to 0.5 and the value of p = 0.5 we get the best 
convergence predictive probability. 
 
Conclusion 
The aim of our work was to propose a simple Bayesian adaptation in 
experimental trials , considered the procedure based on fulfillment of the 
prediction index concept design , we believe that we can say that the 
Bayesian predictive approach proposed can be used to predict on the basis of 
statements frequentist results, we nevertheless believe that the frequentist 
approach sheds a different light on data and should not be excluded from 
further our goal is to develop an effective and flexible design that has 
desirable statistical properties . 
The prediction can also be made to approach the frequentist 
derivatives resulting from the Bayesian approach. We have improved the 
methodology in the design of clinical trials by providing a prediction indices 
in a Bayesian framework, as is always the case in the clinical trial protocol 
and we illustrate our results using the binomial model. 
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We conclude that the predictive probability approach for interim 
control is a coherent, effective and flexible method that more closely 
resembles the process of clinical decision making . 
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